NICE (UK) positive for Lonsurf (tifluridine–tipiracil) + Avastin (bevacizumab) to treat colorectal cancer – Servier
Trifluridine–tipiracil with bevacizumab is NICE recommended, within its marketing authorisation, for treating metastatic colorectal cancer in adults who have had 2 lines of treatment (including fluoropyrimidine-, oxaliplatin- and irinotecan-based… read more.